Evidence map›Paper›PMID 40491614›Full record

ArticleCureus2025

Superiority of Surgical Treatment in Stage 2 Acute Empyema: A Perspective on Lung Volume Improvement.

Hiroyasu Matsuoka, Hirochika Matsubara, Mio Ota, Hiroyuki Nakajima

Abstract read
In one paragraph

Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Hiroyasu MatsuokaSurgery, Kofu Municipal Hospital, Kofu, JPN.
Hirochika MatsubaraThoracic Surgery, University of Yamanashi, Kofu, JPN.
Mio OtaSurgery, Kofu Municipal Hospital, Kofu, JPN.
Hiroyuki NakajimaThoracic Surgery, University of Yamanashi, Kofu, JPN.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionEarly surgery for acute empyema can shorten hospitalization and reduce complications, especially in Stage 2 cases. Inflammation and fibrosis can impair long-term pulmonary function, but few studies have evaluated post-treatment lung recovery. We hypothesized that surgery promotes better lung re-expansion than drainage alone. To test this hypothesis, we analyzed lung volume changes on computed tomography (CT) scans before and after treatment.

methodsThis retrospective, single-center study included adult patients with Stage 2 acute empyema treated from 2012 to 2024 at Kofu Municipal Hospital, Kofu, Japan. Patients were included if they had CT scans before treatment and at least one month after discharge. CT-based lung volumes were analyzed using SYNAPSE VINCENT

resultsAmong 131 Stage 2 empyema cases, 25 met the inclusion criteria (10 surgery and 15 drainage). Surgery was performed after a median of seven days due to poor drainage. The surgery group showed significantly better lung improvement (82% vs. 68%, p < 0.01). Hospital stay and drainage duration were similar, but antibiotic use tended to be longer in the drainage group. After matching (nine patients per group), lung improvement remained superior in the surgery group (79% vs. 66%, p = 0.012). A statistically significant time-dependent improvement in total lung volume was observed in the surgery group following treatment (p = 0.04). DISCUSSION: Surgical intervention led to better lung volume recovery than drainage alone. However, selection bias may exist, as surgery was often delayed until after drainage failure. In three cases, limited decortication may have reduced recovery. This study only included patients with follow-up CT scans and good outcomes, potentially underestimating the full impact of treatment. Early surgical intervention may provide greater benefits by preventing disease progression and facilitating lung re-expansion.

conclusionSurgery for Stage 2 acute empyema significantly improves post-treatment lung volume recovery. Early surgical intervention should be considered in appropriate cases to optimize pulmonary outcomes.

Indexed as

drainageempyemalung volumestage 2surgical treatment

Identifiers

PMID40491614
PMCPMC12148506

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.